Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,896.00
Bid: 11,892.00
Ask: 11,896.00
Change: 544.00 (4.79%)
Spread: 4.00 (0.034%)
Open: 11,890.00
High: 12,086.00
Low: 11,790.00
Prev. Close: 11,352.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

27 Sep 2021 09:00

Small study shows antibody growth from AstraZeneca, Sputnik Light COVID-19 vaccine mix

MOSCOW, Sept 27 (Reuters) - A small-scale clinical study of the combined use of the AstraZeneca and Sputnik Light vaccines against COVID-19 has shown strong antibody growth in a majority of the study's participants, the Russian Direct Investment F...

Read more
27 Sep 2021 06:00

INSIGHT-Global vaccines project to revamp rules after Britain got more than Botswana

* COVAX assigned early Pfizer shots to vaccination leaders UK, UAE* Dose-sharing methodology doesn't check states' vaccine coverage* Vaccine alliance Gavi is proposing changes - internal document* UK was among few countries that had Pfizer freezer...

Read more
24 Sep 2021 12:34

LIVE MARKETS-Evergrande: just a wake call?

* European stock fall* Wall Street futures lower* Evergrande fears persist* Yields march on higherSept 24 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.re...

Read more
24 Sep 2021 12:27

LIVE MARKETS-Tina is still around

* European stock fall* Wall Street futures lower* Evergrande fears persist* Yields march on higherSept 24 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.re...

Read more
24 Sep 2021 12:14

LONDON MARKET MIDDAY: Stocks fall as Evergrande silence sparks fear

LONDON MARKET MIDDAY: Stocks fall as Evergrande silence sparks fear

Read more
24 Sep 2021 10:58

LIVE MARKETS-You're nEver(grande) gonna believe it

* European stock fall* Wall Street futures lower* Evergrande fears persist* Yields march on higherSept 24 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.re...

Read more
24 Sep 2021 10:36

LIVE MARKETS-Bank stocks: forget China, look at rates

Sept 24 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comBANK STOCKS? FORGET CHINA, LOOK AT RATES (0935 GMT)Higher rates expectati...

Read more
24 Sep 2021 09:46

UPDATE 2-European stocks slip on Evergrande woes, weak German business morale

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Friday's declines cut Europe's weekly gains* Germans head to vote on Sunday* Adidas, Puma slide after Nike warning (Adds comments, updates...

Read more
24 Sep 2021 09:31

UPDATE 2-FTSE 100 slips as slowdown worries, inflation fears persist

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* AstraZeneca jumps on positive cancer drug trial results* Growth fears cause hefty drop in UK consumer confidence* Outsourcer Mitie Group ga...

Read more
24 Sep 2021 09:02

LONDON MARKET OPEN: JD Sports falls after Nike cuts revenue forecast

LONDON MARKET OPEN: JD Sports falls after Nike cuts revenue forecast

Read more
24 Sep 2021 08:28

LIVE MARKETS-Europe's shares slide, but still set for weekly gains

Sept 24 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comEUROPE'S SHARES SLIDE, BUT STILL SET FOR WEEKLY GAINS (0725 GMT)European s...

Read more
24 Sep 2021 07:47

AstraZeneca's Lynparza meets primary endpoint in prostate cancer trial

AstraZeneca's Lynparza meets primary endpoint in prostate cancer trial

Read more
24 Sep 2021 07:28

AstraZeneca reports latest positive results for 'Lynparza'

(Sharecast News) - AstraZeneca said on Friday that positive high-level results from the 'PROpel' phase 3 trial showed 'Lynparza', or olaparib, in combination with abiraterone, demonstrated a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) versus standard-of-care abiraterone, as a first-line treatment for men with metastatic castration-resistant prostate cancer (mCRPC), with or without homologous recombination repair (HRR) gene mutations.

Read more
23 Sep 2021 17:58

Panama approaching herd immunity against COVID-19, president says

PANAMA CITY, Sept 23 (Reuters) - Panama is weeks away from achieving herd immunity against COVID-19 after vaccinating more than half its population of 4.2 million people, President Laurentino Cortizo said on Thursday at the United Nations General...

Read more
23 Sep 2021 07:00

AstraZeneca invests in Imperial's self-amplifying RNA technology with eye on future drugs

By Alistair SmoutLONDON, Sept 23 (Reuters) - AstraZeneca Plc on Thursday struck a deal with the firm behind Imperial College London's experimental COVID-19 vaccine to develop and sell drugs based on its self-amplifying RNA technology platform in o...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.